Analytical Development
Analytical Method Development & Validation Services
Reliable analytical solutions designed for pharmaceutical quality, compliance, and regulatory success.
- Typical timeline
- 4–20 weeks
- Clients served
- 800+
- Countries
- 64
Our Approach to Analytical Development
Our analytical method development and validation services help pharmaceutical and biotech companies build accurate, reliable, and regulator-ready analytical procedures. We combine scientific expertise with modern analytical techniques to develop methods that improve product understanding, support quality control, and ensure long-term reproducibility. From early-stage method development to validation, impurity profiling, and regulatory documentation, we provide end-to-end support with a strong focus on compliance, efficiency, and data integrity.
Explore Our Analytical Expertise
Analytical Method Development
- Assay and dissolution method development
- Chromatographic method optimization
- Method robustness evaluation
- Product-specific analytical solutions
Analytical Method Validation
- Accuracy and precision evaluation
- Specificity and linearity assessment
- LOD and LOQ determination
- Validation protocol preparation
Stability-Indicating Method Development
- Forced degradation studies
- Stability-indicating assay methods
- Degradation pathway analysis
- Shelf-life supporting data generation
Impurity Profiling & Characterization
- Related substance analysis
- Residual solvent testing
- Unknown impurity identification
- Degradation impurity characterization
Cleaning Validation Analytical Support
- Residue detection methods
- Swab and rinse sample analysis
- Cleaning process verification
- Validation sample testing support
Regulatory Documentation & Method Transfer
- Analytical regulatory documentation
- Method transfer protocols
- CMC analytical support
- Regulatory submission assistance
Our Analytical Development Process
-
Analytical Requirement Assessment
We begin by understanding your product, analytical goals, regulatory requirements, and testing challenges to design the right analytical strategy.
-
Method Development & Optimization
Our scientists develop and optimize analytical methods that improve sensitivity, specificity, accuracy, and reproducibility for your product.
-
Method Validation
Next, we validate analytical procedures according to ICH and regulatory guidelines to ensure reliable and compliant analytical performance.
-
Data Review & Documentation
We prepare detailed analytical reports, validation documentation, and regulatory-ready data packages to support audits and submissions.
-
Regulatory & Lifecycle Support
Finally, we provide method transfer assistance, ongoing analytical support, and lifecycle management to maintain long-term compliance and consistency.
Our Commitment to Quality & Regulatory Compliance
Regulatory Standards We Follow
- ICH Q2(R2) Analytical Validation Guidelines
- ICH Q14 Analytical Procedure Development
- US FDA Analytical Method Guidance
- EMA Analytical Compliance Standards
- USP & Pharmacopoeial Requirements
Key Analytical Capabilities
- HPLC & UPLC Method Development
- Dissolution & Assay Testing
- Impurity & Stability Analysis
- Cleaning Validation Support
- Analytical Method Transfer
Who it's for
- Pharmaceutical Manufacturers
- Biotechnology Companies
- Generic Drug Developers
- Contract Research Organizations
- Quality Control Laboratories
Why Choose Us for Analytical Method Development & Validation?
At Indivirtus, we combine scientific expertise, regulatory understanding, and practical analytical experience to deliver reliable analytical solutions that support product quality and compliance. Our team focuses on developing robust and reproducible methods that improve analytical accuracy, streamline regulatory submissions, and support long-term manufacturing success. With a strong commitment to data integrity, technical excellence, and regulatory readiness, we help pharmaceutical companies achieve faster approvals and consistent product performance.
- Clients served
- 800+
- Countries
- 64
- Regulatory acceptance
- 100%